GSA Capital Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $564K | Buy |
+21,283
| New | +$564K | 0.04% | 837 |
|
|
2025
Q1 | – | Sell |
-5,522
| Closed | -$222K | – | 2106 |
|
|
2024
Q4 | $222K | Sell |
5,522
-2,638
| -32% | -$106K | 0.02% | 1367 |
|
|
2024
Q3 | $517K | Buy |
8,160
+3,202
| +65% | +$203K | 0.04% | 878 |
|
|
2024
Q2 | $263K | Buy |
+4,958
| New | +$263K | 0.02% | 1341 |
|
|
2024
Q1 | – | Sell |
-68,415
| Closed | -$1.27M | – | 1994 |
|
|
2023
Q4 | $1.27M | Sell |
68,415
-21,326
| -24% | -$397K | 0.11% | 278 |
|
|
2023
Q3 | $993K | Buy |
89,741
+29,319
| +49% | +$324K | 0.09% | 401 |
|
|
2023
Q2 | $979K | Sell |
60,422
-55,618
| -48% | -$901K | 0.1% | 325 |
|
|
2023
Q1 | $1.93M | Sell |
116,040
-99,611
| -46% | -$1.66M | 0.19% | 79 |
|
|
2022
Q4 | $2.03M | Sell |
215,651
-5,832
| -3% | -$54.8K | 0.25% | 27 |
|
|
2022
Q3 | $602K | Buy |
221,483
+54,127
| +32% | +$147K | 0.08% | 441 |
|
|
2022
Q2 | $484K | Buy |
167,356
+27,692
| +20% | +$80.1K | 0.07% | 525 |
|
|
2022
Q1 | $419K | Buy |
139,664
+62,964
| +82% | +$189K | 0.06% | 658 |
|
|
2021
Q4 | $353K | Buy |
76,700
+23,122
| +43% | +$106K | 0.04% | 826 |
|
|
2021
Q3 | $336K | Buy |
53,578
+19,618
| +58% | +$123K | 0.03% | 945 |
|
|
2021
Q2 | $203K | Sell |
33,960
-25,681
| -43% | -$154K | 0.02% | 1179 |
|
|
2021
Q1 | $377K | Sell |
59,641
-13,458
| -18% | -$85.1K | 0.06% | 511 |
|
|
2020
Q4 | $412K | Buy |
73,099
+62,198
| +571% | +$351K | 0.07% | 546 |
|
|
2020
Q3 | $63K | Buy |
+10,901
| New | +$63K | 0.01% | 1174 |
|
|
2019
Q1 | – | Sell |
-13,507
| Closed | -$103K | – | 1705 |
|
|
2018
Q4 | $103K | Sell |
13,507
-7,593
| -36% | -$57.9K | 0.01% | 1217 |
|
|
2018
Q3 | $368K | Sell |
21,100
-35,200
| -63% | -$614K | 0.02% | 1229 |
|
|
2018
Q2 | $534K | Buy |
+56,300
| New | +$534K | 0.03% | 1127 |
|